BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29023184)

  • 1. Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease.
    Alibhai J; Diack A; Manson J
    Prion; 2017 Nov; 11(6):381-387. PubMed ID: 29023184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of Misfolded Prion Protein Seeding Activity Alone Does Not Predict Regions of Neurodegeneration.
    Alibhai J; Blanco RA; Barria MA; Piccardo P; Caughey B; Perry VH; Freeman TC; Manson JC
    PLoS Biol; 2016 Nov; 14(11):e1002579. PubMed ID: 27880767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia in Prion Diseases: Angels or Demons?
    Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
    Ma J; Zhang J; Yan R
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders.
    Risen SJ; Boland SW; Sharma S; Weisman GM; Shirley PM; Latham AS; Hay AJD; Gilberto VS; Hines AD; Brindley S; Brown JM; McGrath S; Chatterjee A; Nagpal P; Moreno JA
    ACS Chem Neurosci; 2024 Apr; 15(7):1533-1547. PubMed ID: 38507813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of astrocytes in prion-like mechanisms of neurodegeneration.
    Smethurst P; Franklin H; Clarke BE; Sidle K; Patani R
    Brain; 2022 Mar; 145(1):17-26. PubMed ID: 35265969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
    Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
    Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained translational repression by eIF2α-P mediates prion neurodegeneration.
    Moreno JA; Radford H; Peretti D; Steinert JR; Verity N; Martin MG; Halliday M; Morgan J; Dinsdale D; Ortori CA; Barrett DA; Tsaytler P; Bertolotti A; Willis AE; Bushell M; Mallucci GR
    Nature; 2012 May; 485(7399):507-11. PubMed ID: 22622579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Microglial Inflammation in Prion Disease.
    Ano Y; Sakudo A; Onodera T
    Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished Neuronal ESCRT-0 Function Exacerbates AMPA Receptor Derangement and Accelerates Prion-Induced Neurodegeneration.
    Lawrence JA; Aguilar-Calvo P; Ojeda-Juárez D; Khuu H; Soldau K; Pizzo DP; Wang J; Malik A; Shay TF; Sullivan EE; Aulston B; Song SM; Callender JA; Sanchez H; Geschwind MD; Roy S; Rissman RA; Trejo J; Tanaka N; Wu C; Chen X; Patrick GN; Sigurdson CJ
    J Neurosci; 2023 May; 43(21):3970-3984. PubMed ID: 37019623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Homeostatic Microglia Signature in Prion Diseases.
    Wang Y; Hartmann K; Thies E; Mohammadi B; Altmeppen H; Sepulveda-Falla D; Glatzel M; Krasemann S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
    Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
    J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Glial Cells in Neurobiology and Prion Neuropathology.
    Hay A; Popichak K; Moreno J; Zabel M
    Cells; 2024 May; 13(10):. PubMed ID: 38786054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.
    Zhou M; Ottenberg G; Sferrazza GF; Hubbs C; Fallahi M; Rumbaugh G; Brantley AF; Lasmézas CI
    Brain; 2015 Apr; 138(Pt 4):992-1008. PubMed ID: 25678560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.